CASE NO. 3:19-CV-02573 (N.D. CAL.)
LGN serves on the Executive Committee in a proposed class action lawsuit against drug manufacturer Gilead and other major drug manufacturers including Johnson & Johnson, Bristol-Meyers Squibb and others. We allege that these drug manufacturers knowingly colluded to raise the price of anti-HIV drugs and as a result, they illegally raised the price of treatment for approximately 1 million people in the U.S. currently living with Human Immunodeficiency Virus-1 (HIV) infection. The case is pending in the United States District Court for the Northern District of California before the Honorable Edward M. Chen.